Effects of tailored telemonitoring on functional status and health-related quality of life in patients with heart failure
| Autor: | G. J. De Weerd, Arno J. Gingele, G. Cleuren, Johannes A. Kragten, H. P. Brunner-La Rocca, Hubertus J. M. Vrijhoef, Christian Knackstedt, Josiane Boyne, J. M. van Empel, K. van der Weg, Anton P.M. Gorgels, Bram Ramaekers |
|---|---|
| Přispěvatelé: | MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), MUMC+: KIO Kemta (9), RS: CAPHRI - R2 - Creating Value-Based Health Care, Cardiologie, RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Spec Cardiologie (9), RS: CARIM - R2.02 - Cardiomyopathy, RS: Carim - H01 Clinical atrial fibrillation, RS: CARIM - R2.01 - Clinical atrial fibrillation, Family Medicine and Chronic Care |
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Visual analogue scale Health-related quality of life Population Heart failure 030204 cardiovascular system & hematology Metabolic equivalent law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Quality of life law medicine PROGRAM Outpatient clinic KNOWLEDGE 030212 general & internal medicine education Rating of perceived exertion education.field_of_study business.industry Hazard ratio Telemedicine SELF-CARE Physical therapy UPDATE Original Article business Cardiology and Cardiovascular Medicine |
| Zdroj: | Netherlands Heart Journal, 27(11), 565-574. Bohn Stafleu van Loghum Netherlands Heart Journal |
| ISSN: | 1568-5888 |
| Popis: | Background Functional status and health-related quality of life (HRQoL) are important in patients with heart failure (HF). Little is known about the effect of telemonitoring on functional status and HRQoL in that population. Methods and results A total of 382 patients with HF (New York Heart Association class 2–4) were included in a randomised controlled trial to investigate the effect of tailored telemonitoring on improving HRQoL and functional status in HF patients. Randomisation was computer-generated with stratification per centre. At baseline and after 12 months, patients’ functional status was determined by metabolic equivalent scores (METS). HRQoL was measured with the EuroQol five dimensions questionnaire (EQ-5D), visual analogue scale (VAS) and Borg rating of perceived exertion scale (Borg). Additional outcome data included number of HF-related outpatient clinic visits and mortality. Telemonitoring was statistically significantly related to an increase in METS after 1 year (regression coefficient 0.318; p = 0.01). Telemonitoring did not improve Borg, EQ-5D or VAS scores after 1 year. EQ-5D [hazard ratio (HR) 0.20, 95% confidence interval (CI) 0.07–0.54], VAS (HR 0.98, 95% CI 0.96–0.99), Borg (HR 1.21, 95% CI 1.11–1.31) and METS (HR 0.73, 95% CI 0.58–0.93) at baseline were significantly associated with survival after 12 months. Conclusions Tailored telemonitoring stabilised the functional status of HF patients but did not improve HRQoL. Therefore, telemonitoring may help to prevent deterioration of exercise capacity in patients with HF. However, because our study is a reanalysis of a randomised controlled trial (RCT), this is considered hypothesis-generating and should be confirmed by adequately powered RCTs. Electronic supplementary material The online version of this article (10.1007/s12471-019-01323-x) contains supplementary material, which is available to authorized users. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink